Literature DB >> 15946246

Close encounters of the monoamine kind: immune cells betray their nervous disposition.

Elizabeth J Meredith1, Anita Chamba, Michelle J Holder, Nicholas M Barnes, John Gordon.   

Abstract

Here we review the evidence for immune cells expressing multiple components of the serotonergic and dopaminergic systems that are more commonly associated with the central nervous system (CNS). We discuss where and how peripheral encounters with these biogenic monoamines occur and posit reasons as to why the immune system would wish to deploy these pathways. A full taxonomy of serotonergic and dopaminergic constituents and their workings in component cells of the immune system should facilitate the formulation of novel therapeutic approaches in diseases characterized by immune dysfunction and potentially provide a range of surrogate peripheral markers for registering and monitoring disturbances within the CNS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946246      PMCID: PMC1782168          DOI: 10.1111/j.1365-2567.2005.02166.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  48 in total

1.  In vivo administration of L-dopa or dopamine decreases the number of splenic IFN gamma-producing cells.

Authors:  Laurence Carr; Alison Tucker; Rafael Fernandez-Botran
Journal:  J Neuroimmunol       Date:  2003-04       Impact factor: 3.478

2.  Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.

Authors:  F McKenna; P J McLaughlin; B J Lewis; G C Sibbring; J A Cummerson; D Bowen-Jones; R J Moots
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

3.  Monoamine neurotoxins-induced apoptosis in lymphocytes by a common oxidative stress mechanism: involvement of hydrogen peroxide (H(2)O(2)), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors.

Authors:  Marlene Jimenez Del Rio; Carlos Velez-Pardo
Journal:  Biochem Pharmacol       Date:  2002-02-15       Impact factor: 5.858

4.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

5.  5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors.

Authors:  Adamantios Serafeim; Gillian Grafton; Anita Chamba; Christopher D Gregory; Randy D Blakely; Norman G Bowery; Nicholas M Barnes; John Gordon
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

6.  Catecholamines in a macrophage cell line.

Authors:  Scott W Brown; Randall T Meyers; Karen M Brennan; Julie M Rumble; Nedathur Narasimhachari; Edmund F Perozzi; John J Ryan; Jennifer K Stewart; Krista Fischer-Stenger
Journal:  J Neuroimmunol       Date:  2003-02       Impact factor: 3.478

7.  Effects of D2-dopamine and alpha-adrenoceptor antagonists in stress induced changes on immune responsiveness of mice.

Authors:  Anna Fiserová; Miroslav Starec; Markéta Kuldová; Hana Kovárů; Marek Páv; Luca Vannucci; Miloslav Pospísil
Journal:  J Neuroimmunol       Date:  2002-09       Impact factor: 3.478

8.  Serotonin upregulates the activity of phagocytosis through 5-HT1A receptors.

Authors:  M Freire-Garabal; M J Núñez; J Balboa; P López-Delgado; R Gallego; T García-Caballero; M D Fernández-Roel; J Brenlla; M Rey-Méndez
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas.

Authors:  I C Anthony; D H Crawford; J E Bell
Journal:  Brain       Date:  2003-05       Impact factor: 13.501

10.  Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.

Authors:  Adamantios Serafeim; Michelle J Holder; Gillian Grafton; Anita Chamba; Mark T Drayson; Quang T Luong; Christopher M Bunce; Christopher D Gregory; Nicholas M Barnes; John Gordon
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

View more
  24 in total

Review 1.  Perspective is everything: an irreverent discussion of CNS-immune system interactions as viewed from different scientific traditions.

Authors:  Monica J Carson; David D Lo
Journal:  Brain Behav Immun       Date:  2007-01-17       Impact factor: 7.217

Review 2.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

3.  Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.

Authors:  János Kálmán; András Palotás; Anna Juhász; Agnes Rimanóczy; Marietta Hugyecz; Zsuzsa Kovács; Gabriella Galsi; Zoltán Szabó; Magdolna Pákáski; Liliána Z Fehér; Zoltán Janka; László G Puskás
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

Review 4.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

5.  Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death.

Authors:  Agata M Wasik; Michael N Gandy; Matthew McIldowie; Michelle J Holder; Anita Chamba; Anita Challa; Katie D Lewis; Stephen P Young; Dagmar Scheel-Toellner; Martin J Dyer; Nicholas M Barnes; Matthew J Piggott; John Gordon
Journal:  Invest New Drugs       Date:  2011-08-18       Impact factor: 3.850

Review 6.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

Review 7.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

8.  Serotonin uptake is largely mediated by platelets versus lymphocytes in peripheral blood cells.

Authors:  Brendan S Beikmann; Ian D Tomlinson; Sandra J Rosenthal; Anne Milasincic Andrews
Journal:  ACS Chem Neurosci       Date:  2012-10-22       Impact factor: 4.418

9.  Inflammatory vulnerability associated with the rh5-HTTLPR genotype in juvenile rhesus monkeys.

Authors:  W Z Amaral; G R Lubach; A J Bennett; C L Coe
Journal:  Genes Brain Behav       Date:  2013-02-27       Impact factor: 3.449

10.  Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation.

Authors:  Dakshayani Kadiyala Babu; Alain Diaz; Thangavel Samikkannu; Kurapati V K Rao; Zainulabedin M Saiyed; Jose W Rodriguez; Madhavan P N Nair
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.